Exicure Inc
Research Exicure Inc (XCUR) on Bullrun: market cap USD 14.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerXCUR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 14.02M
- Financial periodFY2025
- Revenue growth-100.0%
- Net income-USD 4.95M
- Free cash flow-USD 8.56M
Valuation Snapshot
latest market cap is USD 14.02M.
About Exicure Inc
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Frequently asked questions
What is Exicure Inc's market cap?
Exicure Inc's market capitalization is USD 14.02M.
What does Exicure Inc do?
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd.